Graft
Graft operates as a cloud-native platform. It empowers organizations to wield advanced artificial intelligence (AI) techniques to unlock the value of text, images, video, audio, and graphs. The company was founded in 2021 and is based in San Francisco, California.
Headquarters Location
966 Carolina Street
San Francisco, California, 94107,
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Expert Collections containing Graft
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Graft is included in 1 Expert Collection, including Artificial Intelligence.
Artificial Intelligence
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
Graft Patents
Graft has filed 4 patents.
The 3 most popular patent topics include:
- Artificial neural networks
- Data management
- Data types
Data management, Artificial neural networks, Database management systems, Machine learning, Planetary systems
Data management, Artificial neural networks, Database management systems, Machine learning, Planetary systems
Latest Graft News
Pune, INDIA Pune, India., May 18, 2023 (GLOBE NEWSWIRE) — The Insight Partners published latest research report on " Skin Graft Market Forecast to 2028 — COVID-19 Impact and Global Analysis By Product, Graft Thickness, Application, Equipment, and End User and Geography”, the global market size is projected to reach US$ 1,673.5 million by 2028 which was valued at US$ 985.4 million in 2020; it is expected to grow at a CAGR of 7% from 2021 to 2028. Request Sample PDF Brochure: https://www.theinsightpartners.com/sample/TIPHE100001099 Growth Strategies by the Key Players Operating in the Skin Graft Market: Sep 2020 — MiMedx Group, Inc. launched EpiCord Expandable, the latest advancement in its portfolio of products. At the core of this technology is EpiCord, which has demonstrated clinical efficacy in the treatment of diabetic foot ulcers. May 2019 — The company received contract for the PuraPly Antimicrobial (PuraPly AM), Apligraf, Dermagraft, NuShield and other products advanced wound care. Vizient, is one of the largest health care performance improvement company with over 3,100 hospital and health system members. Apr 2019 — Smith and Nephew has acquired skin substitute manufacturer Osiris Therapeutics for US$ 660 million. This acquisition is expected to expand Smith and Nephew's portfolio in advanced wound management. Jan 2019 — The RECELL Autologous Cell Harvesting Device (RECELL System) was launched in the United States by AVITA Medical for the treatment of acute thermal burns in patients aged 18 and up. Skin grafting is a surgery involving the transplantation of skin using various types of skin graft. Skin grafts are also used to treat extensive wounding or trauma and burns. Skin graft is small patch of skin, which is removed from skin of the other part of the patient’s body by a surgery. The patch of skin is transplanted or attached to the injured sit or the burnt site. Diabetes is among the most common health conditions prevalent across the globe. According to the International Diabetes Federation’s (IDF) IDF Diabetes Atlas Ninth edition 2019,
463 million adults were living with diabetes worldwide. The prevalence is estimated to be 700 million by 2045—nearly 79% of adults living with diabetes in low-and-middle incomes countries worldwide. Among the prevalence of diabetes, the proportion of type 2 diabetes is increasing at a much faster rate. According to the IDF, 374 million are at risk of developing type 2 diabetes in the coming future. Among diabetic patients, wound healing is prolonged, which increases the risk of skin infections if it is not healed within a particular time.
25% of diabetic patients are likely to develop foot ulcers once in their lifetime that often need advanced diabetic wound care. Therefore, there is an increase in demand for skin grafts to treat or cover diabetic foot ulcers by eliminating the chances of contracting skin infections. Thus, the high prevalence rate of skin cancer and diabetes is expected to drive skin graft market in the near future. Directly Purchase Premium Copy of Skin Graft Market Growth Report (2021-2028) at: https://www.theinsightpartners.com/buy/TIPHE100001099 Several in organic approaches, such as product launches, and expansion in the skin graft, have resulted in the growth of the market. Likewise, inorganic strategies such as mergers & acquisitions, and collaboration have help the company to strengthen its revenue, which allows the company to hold a strong position in the market. Skin grafts are ideally preferred post-surgery for skin cancers. Skin grafts are generally referred for local postoperative radiotherapy (PORT) to ensure closure of surgical bed created during radiotherapy . According to Cancer Research UK,
15,400 new melanoma skin cancer cases are registered in the UK every year, accounting for 42 new cases every day. Incidence rates for melanoma skin cancer are projected to rise by 7% in the UK between 2014 and 2035, to 32 cases per 100,000 people by 2035. Likewise, according to the recent statistics published by the International Agency for Research on Cancer, in 2020, 19.3 million new cancer cases were registered, excluding 18.1 million for nonmelanoma skin cancer. Thus, an increase in the prevalence of skin cancer is likely to contribute to skin grafting in the coming future. Global Skin Graft Market Share Report, Segmentations, Regional & Country Scope: Report Coverage
Built for the 99%
We’re on a mission to bring the capabilities of the world’s leading AI companies to every business. That’s an ambitious goal, but almost as ambitious is how we plan to get there.
Our mission
Make the AI of the 1% accessible to the 99%.
Our vision
Access to AI is not equal, due to a lack of the data, infrastructure, and expertise required to practice it in production.
Graft removes these barriers to entry, making modern AI accessible to every person in every organization. No need to hire a special team or bottleneck on them to get anything done.
Our values
We are building a diverse team with a variety of skills and backgrounds. We’re focusing on customer success, not vanity metrics. We’re rewarding behaviors that reflect our values, like collaboration and communication, and encouraging a bias for action and a sense of ownership. We do all this because Graft is building the future of AI, and this is how the future should look.
Graft: как создать собственный ИИ без специальных знаний
Традиционно принято считать, что создание и обучение искусственного интеллекта (ИИ) требует специальных знаний и навыков, которые не доступны большинству людей. Однако существует Стартап Graft, который стремится сделать ИИ доступным для всех, предоставляя простой и удобный интерфейс для создания своих собственных проектов. Эту новость сообщил Yahoo 26 июля 2023 года, ссылаясь на Tech Crunch.
Платформа Graft основана на принципах простоты и доступности. Она использует визуальный редактор, который позволяет пользователям создавать модели ИИ без необходимости писать код. Платформа также предлагает множество обучающих материалов, которые помогут пользователям узнать больше об ИИ.
Graft основана в 2021 году двумя бывшими сотрудниками Google, которые заметили, что многие люди хотели бы использовать ИИ для своих целей, но не имели достаточных ресурсов или опыта для этого. Поэтому они решили создать платформу, которая бы позволяла любому человеку создавать ИИ с помощью простых шагов и визуальных элементов. Платформа Graft позволяет выбирать тип ИИ, который нужен для задачи, загружать свои данные или использовать готовые наборы данных, настраивать параметры обучения и запускать свой ИИ в облаке или на своем устройстве.
Платформа Graft не только упрощает создание ИИ, но и помогает улучшить его качество и эффективность. Платформа использует передовые алгоритмы и технологии, такие как обучение с подкреплением, нейронные сети и оптимизация гиперпараметров, чтобы обеспечить высокую точность и скорость работы ИИ. Кроме того, платформа Graft поддерживает различные форматы данных, такие как текст, изображения, аудио и видео, и позволяет интегрировать ИИ с разными приложениями и платформами, такими как веб-сайты, мобильные устройства и облачные сервисы.
GRAFT was established in 1998 in Los Angeles, California, by Lars Krückeberg, Wolfram Putz and Thomas Willemeit. Further offices followed in Berlin, Germany, in 2001 and Beijing, China, in 2004. In 2018, GRAFT expanded its management team, welcoming Sven Fuchs and Georg Schmidthals as new partners.
GRAFT is conceived as a studio for architecture, urban planning, design, music and the pursuit of happiness. Since its establishment, it has been commissioned to design and manage a wide range of projects across multiple disciplines and in numerous locations. Although the company’s core enterprises gravitate around the field of architecture and the built environment, GRAFT has always maintained an interest in crossing the boundaries between disciplines and “grafting” the creative potential and methodologies of different realities. This is reflected in its expansion into the fields of exhibition and product design, art installations and academic projects, as well as in their variety of project locations around the world. GRAFT’s collective professional experience encompasses a wide range of building types, including residential, cultural, educational, institutional, commercial, master plan and healthcare projects. GRAFT has won numerous international awards, and now numbers some 100 members of staff from over 20 nations.
Lars Krückeberg, Wolfram Putz and Thomas Willemeit have held several guest professorships in the USA and Germany and are members of the expert team of the Zukunftsinstitut think tank.
In 2007, together with Brad Pitt, Bill McDonough and the Cherokee Foundation, GRAFT established the Make It Right Foundation, whose objective was the rebuilding of New Orleans’ Lower 9th Ward after Hurricane Katrina.
GRAFT’s self-initiated projects also include SOLARKIOSK, a company founded with the German lawyer Andreas Spieß in 2009 to bring clean energy, connectivity and solar products to rural areas in sub-Saharan Africa. And, in 2015, GRAFT co-founded Heimat2 with H. W. Pausch, Sven Rawe and Dr. Gerd Ellinghaus, which aims to bring dignified housing solutions to refugees in Europe.
In 2014, in collaboration with branding expert Linda Stannieder, GRAFT’s founding partners set up the GRAFT Brandlab agency, enabling an additional focus on communication design, brand strategy and consultancy while staying true to GRAFT’s multidisciplinary approach and working methods. Through progressive brand innovation concepts and a multidimensional approach, the agency places greater focus on enriching the interface between digital and physical brand experiences within constantly evolving markets and cultures. Today, the agency is led by Nikolaus Hafermaas and Rico Zocher.